Following the U.S. Environmental Protection Agency’s (EPA) 2016 finding declaring ethylene oxide (EtO), a powerful chemical popularly used for sterilizing medical devices, to be significantly more dangerous than prior understanding, a floodgate of lawsuits has opened against multiple EtO-using entities across the United States. The domino effect has shown no signs of slowing, as the nature and implications of this issue continues to evolve within the legal landscape.
EtO is prominently used in the healthcare industry due to its effectiveness in sterilizing medical equipment. The EPA’s findings in 2016, however, raised new concerns about the significant health risks associated with its usage, prompting a collective response from both individuals and shareholders. Their grievances, echoed through innumerable lawsuits, assert that the current regulations posed by the EPA are insufficient and questionably late.
From the litigation overview reported by Goldberg Segalla, it is clear that both medical institutions and manufacturers that rely on EtO are under increasing legal scrutiny. As the fallout from the EPA’s findings continue to ripple through the courts, the legal community can expect many more claims of this nature.
It may be apparent that the recent torrent of legal action points towards the need for more robust regulations and guidelines governing the use of EtO. In the face of this backlash, the EPA’s stance and future actions regarding EtO regulations will undoubtedly impact both the legal and medical sectors in the United States.
As the consequences of these findings continue to unfold, it is crucial for legal professionals within the healthcare industry, among others, to be prepared for potential litigation and understand the ongoing developments surrounding this substance.